Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: Results of a 6-month open-label safety trial

BACKGROUND: Chronic liver injury can result in fibrosis that may progress over years to end-stage liver disease. The most effective anti-fibrotic therapy is treatment of the underlying disease, however when not possible, interventions to reverse or slow fibrosis progression are needed. AIM: To study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Int
Main Authors: Meissner, Eric G., McLaughlin, Mary, Matthews, Lindsay, Gharib, Ahmed M., Wood, Bradford J., Levy, Elliot, Sinkus, Ralph, Virtaneva, Kimmo, Sturdevant, Dan, Martens, Craig, Porcella, Stephen F., Goodman, Zachary D., Kanwar, Bittoo, Myers, Robert, Subramanian, Mani, Hadigan, Colleen, Masur, Henry, Kleiner, David E., Heller, Theo, Kottilil, Shyam, Kovacs, Joseph A., Morse, Caryn G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116256/
https://ncbi.nlm.nih.gov/pubmed/27232579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados